TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,000 | +20.0% | 4,338 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -58.3% | 4,338 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $12,000 | -20.0% | 4,338 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $15,000 | +15.4% | 4,338 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $13,000 | -51.9% | 4,338 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $27,000 | +50.0% | 4,338 | +60.9% | 0.00% | 0.0% |
| Q3 2017 | $18,000 | -5.3% | 2,696 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $19,000 | -24.0% | 2,696 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $25,000 | – | 2,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |